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Infection of bare metal stents in the vasculature is rare, but associated with significant morbidity andmortality. We report
two cases of bare metal stent infections and review the literature regarding infected bare metal stents with respect to risk
factors, pathophysiology, diagnosis, treatment, and prevention. Overall, this article highlights the need to have a high
index of suspicion of bare metal stent infection, since prompt diagnosis and treatment can ultimately decrease the
morbidity and mortality associated with this devastating problem. (J Vasc Surg 2007;46:813-20.)Percutaneous transluminal angioplasty (PTA) and en-
dovascular stent placement in the peripheral vasculature is
becoming a prevalent treatment option for atherosclerotic
disease. Problems and complications associated with these
procedures include puncture site hematoma, vessel throm-
bosis, distal embolization, arterial dissection, arterial rup-
ture, failure of stent expansion, stent displacement, stent
malposition, neurologic injury, and pseudoaneurysm for-
mation.1-6 However, infection of bare metal stents in the
peripheral vasculature is not well-reported. Since a report
by Chalmers et al7 in 1993 of a case of arteritis following
placement of a Palmaz stent (Cordis, Miami Lakes, Fla) in
the right common iliac artery (CIA), only scattered case
reports of peripheral bare metal stent infections have been
published over the past 20 years (Table).1,4-33
Vascular graft infection is a well-described problem
with a number of accepted standards for prevention and
treatment. Currently, however, no such standards exist for
managing bare metal stent infections. Furthermore, no
consensus has been reached regarding the need for prophy-
lactic antibiotics prior to stent placement. The type of
sterile environment in which these procedures should be
performed remains a question. In addition, the need for
periprocedural antibiotics during other procedures that
potentially cause transient bacteremia has not been stan-
dardized. Although uncommon, previous case reports have
demonstrated the significant potential for associated mor-
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doi:10.1016/j.jvs.2007.05.043bidity that can be associated with bare metal stent infection.
In this article, we report two cases from our institution and
highlight important aspects of this difficult and dangerous
problem.
CASE REPORTS
Case 1. A 58-year-old male who previously underwent place-
ment of nine bilateral lower extremity bare metal stents (right and
left external iliac artery [EIA], right and left common iliac artery
[CIA], two right and three left superficial femoral artery [SFA])
was transferred to our medical center with left lower extremity
gangrene and necrosis of the left medial knee. He originally
presented to the referring medical center 1 month earlier with
worsening bilateral lower extremity claudication. He was diag-
nosed with left SFA stent occlusion and received tissue plasmino-
gen activator (tPA). He was re-admitted several times for stent
re-occlusion and underwent tPA three times. The last procedure
was complicated by sepsis and a large retroperitoneal bleed.
The patient was transferred to our medical center receiving
piperacillin/tazobactam. Physical examination revealed costo-
vertebral angle tenderness, flank ecchymosis, a palpable right fem-
oral pulse, but no other palpable pulses in either lower extremity.
Examination of the extremities also revealed left medial knee skin
necrosis and dry gangrene of the left first and fifth toes. Laboratory
studies revealed no leukocytosis. Blood cultures were positive for
Staphylococcus aureus. A tagged white blood cell (WBC) scan
localized to both thighs. A computed tomography (CT) scan
showed: (1) aneurysmal dilation (3.6 cm 3.4 cm) of the proximal
left CIA with contrast filling the lumen outside the wall of the stent
consistent with pseudoaneurysm formation and 10.0 cm  10.7
cm retroperitoneal hematoma (Fig 1); (2) a fluid collection (2.8
cm  2.9 cm) surrounding the proximal left SFA stent; and (3) a
fluid collection with air surrounding the distal left SFA stent with
extension into the vastus medialis (Fig 2).
He was taken to the operating room for removal of both CIA
stents, the left EIA stent, and the proximal left SFA stent with
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Author Date Vessel location Stent
Rees8 1991 Renal artery Palmaz
Quinn9 1992 Unknown vein Gianturco
Chalmers7 1993 Right CIA Palmaz
Gunther10 1993 Right coronary artery Palmaz-Schatz
Therasse6 1994 Left CIA; right EIA Palmaz
Liu1 1995 Bilateral CIA Palmaz
Guest11 1995 Right subclavian vein Wallstent
Deiparine12 1996 Right CIA, right CFA, re-PTA right EIA Unknown
Gordon13 1996 Left renal artery Palmaz
Leroy14 1996 LAD Palmaz-Schatz
Weinberg15 1996 Bilateral CIA Palmaz
Hoffman16 1997 Right iliac artery Wallstents
Bunt17 1997 Left EIA Palmaz
Bouchart18 1997 Left circumflex artery Palmaz-Schatz
Deitch19 1998 Renal artery Unknown
DeMaioribus20 1998 Left renal artery Palmaz
Muller21 1998 Left CIA Palmaz
Grewe22 1999 LAD Micro-stent
Schachtrupp5 1999 Left CIA Self-adjusting nitinol
Angiomed
Giannoukas23 1999 Left SFA, left popliteal artery Strecker and Palmaz
Bukhari24 2000 Bilateral renal arteries Palmaz
Naddour25 2000 Right innominate vein and right subclavian vein Wallstent within
previous Wallstent
Rensing26 2000 Obtuse marginal and right coronary artery Unknown
Myles27 2000 Left subclavian artery Palmaz
Myles27 2000 Bilateral CIA and LAD Palmaz
Malek28 2000 Left subclavian artery Palmaz and multilink
premounted stent
Dosluoglu29 2001 Right EIA and right CIA Palmaz
Dosluoglu29 2001 Left CIV Palmaz
Pruitt4 2002 Right subclavian artery and brachiocephalic
artery
Tandem Smart stents
and Palmaz,
respectively
Walton30 2003 Left SFA Unknown
Liu31 2003 LAD NIR
Alfonso32 2005 Right coronary artery Rapamycin eluting
Kaviani33 2006 Left ICA Cordis Precise stent
Present report 2007 Left SFA Unknown
Present report 2007 Bilateral SFA Viabahn and Protégé
ATA, anterior tibial artery; CFA, common femoral artery; CIA, common iliac artery; CIV, common iliac vein; EIA, external iliac artery; ICA, Internal carotid
artery; LAD, left anterior descending; MRSA, methicillin resistant Staphylococcus aureus; N/V, nausea and vomiting; PTA, percutaneous transluminal
angioplasty; SFA, superficial femoral artery.
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Time to
presentation Signs and symptoms Organism
Prophylactic
antibiotics
3 days Unknown Unknown Unknown
2 days Unknown (patient signed out against medical
advice)
Unknown None, but after this
complication the
authors started
2 days Groin pain, fevers, edema, leukocytosis Staphylococcus aureus Unknown
4 weeks Fevers, malaise, pericardial effusion, leukocytosis Staphylococcus aureus Unknown
10 days Fever, chills, abdominal pain, leg pain, petechiae Staphylococcus aureus and
Staphylococcus epidermidis
None
2 days Groin pain, fevers, N/V, chills, abdominal pain, back
pain
Staphylococcus aureus Unknown
24 days Fever, chills, malaise, delirium, right arm and
shoulder edema
Staphylococcus aureus Unknown
9 days Fever, groin pain, petechiae, leukocytosis Staphylococcus aureus and
Escherichia coli
Unknown
10 days Fever, flank pain, nocturia, chills Beta hemolytic
streptococcus
Unknown
7 days Fever, murmur Pseudomonas aeruginosa Unknown
2 days Fever, N/V, groin/abdominal pain, leukocytosis,
petechiae
Staphylococcus aureus None
7 days Abdominal pain, back pain, fever, edema, leg pain,
mottled leg
Staphylococcus aureus Unknown
22 months Sepsis, abdominal/groin pain, petechiae Staphylococcus aureus Unknown
4 days Fevers, chills, chest pain, pericardial effusion Pseudomonas aeruginosa Unknown
3 months Back pain MRSA Unknown
14 days Fever, hypotension, leukocytosis, melena,
abdominal/flank pain
Staphylococcus aureus
(blood/wound) and
Proteus mirabilis (urine)
None
12 days Fever, hypotension, tachycardia, leukocytosis Staphylococcus aureus Unknown
4 days Acute myocardial infarction, fever, leucocytosis,
myocardial abscess
Staphylococcus aureus Unknown
10 days Fever, leukocytosis, malaise, chills, thigh pain, rash Staphylococcus aureus None
2 weeks Claudication, cellulitis, fever, thigh pain MRSA None
6 months Hypertensive crisis, back pain, leukocytosis Unknown Ancef
20 days Fever, chills, weakness, anorexia, shoulder pain, arm
swelling
Staphylococcus aureus Unknown
4 days Fevers, chills, malaise, chest pain Staphylococcus aureus Unknown
2 days Fever, rigors, lethargy, delirium, subclavian, bruit,
leukocytosis
Staphylococcus aureus None
4 days Chills, sweats, fever, leukocytosis Staphylococcus aureus None
6 days Fever, chills, arm pain, tender venous cord,
leukocytosis, skin lesions in arm
Staphylococcus aureus Unknown
Many
months
Abdominal pain, hip pain, fever, malaise,
leukocytosis, edema
MRSA None
4 days Fever, chills, abdominal pain, edema, diarrhea Staphylococcus epidermis None
14 days Malaise, erythematous macular lesions on arm/hand,
arm edema, petechiae, right vision loss, finger
gangrene, septic emboli to brain
Staphylococcus aureus None
Many
months
Left medial calf abscess, pulsatile thigh mass MRSA Unknown
18 days Fever, leukocytosis, chest pain, cardiac abscess Staphylococcus aureus,
simulans, and capitis
Unknown
2 days Fever, chills, malaise Staphylococcus aureus Unknown
20 months Carotid cutaneous fistula with pulsatile mass,
purulent drainage, hemorrhage
Beta hemolytic
streptococcus
None
Unknown Retroperitoneal hematoma, trashed foot Staphylococcus aureus Unknown
1 week Fever, chills, sweats, knee swelling Pseudomonas aeruginosa Unknown
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was used to reconstruct the aortoiliac inflow. The patient returned
to the operating room several days later for removal of the remain-
ing infected left SFA stents, excision of the entire SFA, and creation
of a left profunda femoral to above-knee popliteal artery bypass
graft using orthograde greater saphenous vein through a lateral
approach. Cultures from both surgeries were positive for Staphylo-
coccus aureus. The patient was discharged home on a 6-week
course of ampicillin/sulbactam and subsequently underwent a left
foot transmetatarsal amputation.
Case 2. A 54-year-old male who previously underwent place-
ment of bilateral lower extremity stents was transferred to our
institution for evaluation and treatment of a septic right knee
associated with Pseudomonas aeruginosa bacteremia. Five months
prior to admission the patient underwent placement of three
Viabahn stents (W.L. Gore, Flagstaff, Ariz). The next month, he
underwent additional stenting of the distal right SFAwith two bare
metal nitinol Protégé stents (ev3 inc, Plymouth, Minn). Within
onemonth, the patient developed symptoms of right knee swelling
Fig 1. Computed tomography scan demonstrating a left com-
mon iliac artery aneurysm with contrast visible outside of the stent
(arrow), as well as a large left retroperitoneal hematoma.
Fig 2. Computed tomography scan demonstrating an enhanced
fluid collection around left superficial femoral artery (arrow).and pain. At the referring hospital, he was found to have Pseudo-monas aeruginosa septic arthritis. The patient was treated with
piperacillin/tazobactam and tobramycin sulfate, but eventually
required arthroscopic incision and drainage of the right knee. One
week after completion of an 8-week course of piperacillin/tazobac-
tam and tobramycin sulfate, the symptoms recurred and he was
transferred to our institution for further evaluation and treatment.
On physical examination, the patient was afebrile, but had a
right knee effusion and right calf edema. Pulse examination re-
vealed palpable bilateral femoral and popliteal artery pulses, but no
pulses distally. ABI of the right and left dorsalis pedis were 0.9 and
0.85, respectively. A tagged WBC scan demonstrated increased
uptake in the thigh. A CT scan of the lower extremities revealed:
(1) contiguous stenting along the entire right SFA; (2) a 9 mm 
22 mm fluid collection anterior to the distal aspect of the right SFA
bare metal stent; and (3) soft tissue stranding along the entire SFA.
Magnetic resonance angiography (MRA) of the lower extremities
revealed a 9mm 22mmfluid collection anterior to the distal aspect
of the right SFA stent consistent with a pseudoaneurysm (Fig 3).
The patient was taken to the operating room where the entire
right SFA and popliteal artery were removed and reconstructed
with a right femoral to anterior tibial artery bypass graft using
orthograde greater saphenous vein. The right distal SFA was found
to have a large pseudoaneurysm associated with purulent fluid
surrounding the bare metal stent. Operative cultures were ob-
tained, but were all negative. His postoperative recovery was
unremarkable, and he was discharged to a rehabilitation institute
with oral ciprofloxacin and wound vacuum assisted closure (VACs)
Fig 3. Magnetic resonance angiogram demonstrating a right su-
perficial femoral artery pseudoaneurysm (arrow).(KCI, San Antonio, Tex) for his open thigh wounds.
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A thorough review of the literature was performed from
1966 to present and just over 30 case reports were found
regarding infectious complications following placement of
a bare metal stent (Table). Bare metal stents are commonly
utilized for the treatment of coronary artery disease, renal
artery stenosis, carotid artery stenosis, subclavian/brachio-
cephalic pathology, hemodialysis access sites, and lower
extremity peripheral arterial occlusive disease. The majority
of reports in the literature on infectious complications
following percutaneous stenting does not involve the stent
site but rather involves the common femoral artery access
site. These complications are thought to be more common
with prolonged indwelling catheters or following proce-
dures associated with repeat ipsilateral punctures.34 The
two case reports from our institution (1) highlight multiple
complications of the sequelea of infected bare metal stents
which can occur in any artery; (2) emphasize how a low
index of suspicion leads to a delay in diagnosis; and (3)
convey how aggressive surgical intervention is necessary to
rid the patient of infection.
Risk factors. Upon review of the published reports,
risk factors for bare metal stent infection include: breaks in
sterile technique; occult glove perforation; inadequate skin
preparation; repeat puncture of the same arterial access site
causing needle tract contamination; prolonged use or reuse
of an indwelling catheter; increased procedure time; punc-
ture site hematoma formation; less than ideal aseptic envi-
ronment of angiographic suites; other source of coincident
bacteremia; longer wires and catheters; passing wires or
catheters through previously deployed stents; and deploy-
ment of multiple stents or multiple interventions on the
same or adjacent sites.4,6,12,13,19,20,24,29 Deitch et al re-
ported a case of a 72-year-old woman who underwent
percutaneous transluminal renal angioplasty and stenting
who developed a methicillin-resistant Staphylococcus aureus
line infection. This other source of coincidental bacteremia
subsequently led to an infected pseudoaneurysm of the
renal artery and mycotic aneurysm of the aorta which
required complex revascularization.19 Our first case under-
went repeated access through previously placed stents for
tPA and had prolonged use and reuse of indwelling cathe-
ters, which likely caused seeding of his bare metal stents.
Not all infections have a clearly defined vector of infec-
tion. Kaviani et al report a case of a carotid-cutaneous fistula
20 months after placement of a Precise Stent (Cordis
Endovascular, New Brunswick, NJ) in the left internal
carotid artery.33 The patient underwent coiling of the left
external carotid artery, resection of the left carotid bifurca-
tion, stent removal and reconstruction of the left internal
carotid artery using a saphenous vein interposition graft
and pectoralis myocutaneous flap. The authors postulate
several potential etiologies: (1) transient bacteremia
through the stent causing a superinfection; (2) contamina-
tion during the original procedure; (3) erosion of the stent
into the dermis with paucity of coverage causing seeding
and arteritis secondary to skin flora; and (4) unrecognizedpseudoaneurysm at the bifurcation upon completion of the
original procedure.33 Clearly, for each infection, several
possible scenarios exist with no reliable method to deter-
mine the actual etiology.
Pathophysiology. The natural history of stent infec-
tions involves progressive arterial destruction, stent throm-
bosis, septic embolization, pseudoaneurysm formation, ar-
terial disruption, and hemorrhage.35 The exact pathology
of arteritis from angioplasty and stenting is not completely
understood, but studies in animal models suggest that
stents act as a nidus for colonization or a vector for iatro-
genic introduction.35-37 This occurs either through arterial
trauma incurred during the procedure, ie, denudation of
the endothelial lining, which exposes the arterial media, or
through the stent which acts as a bacterial medium and
sequesters bacteria beneath the struts and then spreads to
the arterial wall. The resulting inflammation causes necrosis
and destruction of the arterial wall, which can lead to
pseudoaneurysm formation and subsequent rupture and
promote platelet adherence and thrombus formation re-
sulting in septic emboli.35
Animal models suggest that poor stent incorporation
predisposes the artery to infection and infection predisposes
to stent thrombosis. Hearn et al and Thibodeaux et al
suggested that poorly incorporated stent/artery complexes
developed infections and intra-arterial stent infection ef-
fected arterial patency because they found that all throm-
bosed stents in their swine model were culture positive and
only culture negative arteries remained patent.36,37 It ap-
pears that neointima formation serves as a protective mea-
sure against infection and that delayed bacterial challenge
after arterial wall incorporation is less likely to result in
infection. However, it cannot be definitively determined
which occurs first, infection prohibiting incorporation or
incorporation prohibiting infection.35 We presented one
case in which the bacteremia likely occurred due to a
delayed bacterial challenge from tPA and prolonged in-
dwelling catheters, and a second case where bacteremia
likely occurred at the time of the initial procedure. The
latter is by far the most common scenario and too early for
stent incorporation. In 18 of 21 infections reported by
Dosluoglu et al, the infections occurred immediately fol-
lowing the procedure. The other three cases of stent infec-
tion occurred after a second intervention through the
stented artery several months after the original proce-
dure.29
Diagnosis. Patients typically present with fever, chills,
malaise, pain, and petechiae (Table). However, stent infec-
tion is often a diagnosis of exclusion after other sources of
bacteremia are exhausted or inconclusive. The most fre-
quently employed modalities to diagnose bare metal stent
infections are CT scans, angiography, ultrasonograpy, and
taggedWBC scans. Additional tests may be necessary when
addressing specific anatomy. CT scans may show findings
of pseudoaneurysm formation, abscess, thrombosis, or
perivascular stranding, but these radiographic findings may
not be apparent when the patient first presents with infec-
tious symptoms. Dosluoglu et al and Pruitt et al recom-
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In the former, seven initial CT scans did not show any
evidence of an infection.29 Pruitt et al reported a case of a
74-year-old female who had undergone PTA and stenting
of subclavian and brachiocephalic arteries for finger isch-
emia with a fatal outcome after mycotic aneurysm forma-
tion and rupture of the brachiocephalic artery. No aneu-
rysm was seen on CT scan from her first admission but a
subsequent CT scan showed a 5 cm  3 cm mycotic
pseudoaneurysm.4
WBC scans are rarely utilized. In a literature review by
Dosluoglu et al of 21 cases of infected stents, only two of
four WBC scans were positive. In our cases, the WBC scans
were positive for both patients. Combining these gives a
sensitivity of 4/6 (67%). However, in our patients, uptake
was identified in nearly all areas where stents were located,
not just locations suspicious for infections, which calls into
question the specificity of the test.
Treatment. Infected endovascular stents pose difficult
management problems. Removal of all infected tissue and
revascularization is often required. Treatment may be mor-
bid and can be technically challenging. When possible, the
use of autologous tissue is preferred. The use of homografts
has recently gained popularity. However, when autologous
conduit or homografts are not available, extra-anatomic
reconstruction with prosthetic material is often required.
Myles et al reviewed the literature concerning infected
stents and found that 13 of 19 cases were treated with
operative intervention with a resultant mortality of 31% (4
of 13).27 Of the remaining six cases, one patient died from
septic shock, one required subsequent amputation due to
pseudoaneurysm rupture, and two developed pseudoaneu-
rysms while being monitored with serial scans.27 Chalmers
et al noted delay in referral for definitive surgical interven-
tion as a contributing factor for severity and progression of
infectious complications.7 Krupski et al included mycotic
aneurysm, recurrent septic emboli, or persistent sepsis as
indications for surgical management.38 Pruitt et al pro-
posed that the development of a pseudoaneurysm is an
indication for operation.4 DeMaioribus et al presented a
case of septic emboli, arterial necrosis and acute renal failure
after placement of a Palmaz stent (Cordis) in the left renal
artery for chronic renal insufficiency and a 70% stenosis.20
The patient ultimately required resection of the left renal
artery and kidney with primary aortic closure. Given the
morbidity of the procedure to remove infected stents,
DeMaioribus et al did not advocate mandatory operation
over the use of antibiotics alone, but rather felt every case
required surgical evaluation and consideration.20 Interest-
ingly, many authors did not comment on the treatment of
choice for infected bare metal stents.
Prevention. No consensus has been reached regard-
ing the prophylactic use of antibiotics for arterial stent
placement. Only one of the case reports reviewed explicitly
discussed the use of prophylactic antibiotics prior to stent
deployment.24 Several authors reported that no antibiotics
were administered.4-6,9,15,20,23,27,29,33 For the majority of
the reports, the use of antibiotics remains unknown. Giventhe low incidence of stent infection, a clinical trial would
not be feasible to answer this question. The main argument
against prophylaxis is that due to the low incidence of stent
infection, the number needed to treat to prevent infection
would be very high. The main argument for prophylaxis is
that the complications from an infected stent can be fatal or
require extensive surgery to treat. Furthermore, most of
these infections occur from contamination at time of pro-
cedure. This concept is not new. A randomized, prospec-
tive, double blind study addressing antibiotic prophylaxis in
vascular surgery was done by Kaiser et al in 1978.39 This
showed graft infection in only 4/462 patients (0.87%).
Given that no side effects occurred as a result of prophylac-
tic antibiotics and given the morbidity and mortality of
graft infections, the authors recommend prophylaxis. Al-
though the results were not statistically significant, all four
infections occurred in the placebo group that did not
receive antibiotics. Some practitioners recommend selec-
tive antibiotic prophylaxis in the following instances: for
stents in veins of hemodialysis access,6,11 access site hema-
toma,6 repeat arterial puncture,6,23,29 diabetic patients,16
immunosuppressed patients,16,29 patients with cirrhosis,16
long catheterization or long indwelling sheaths,28,29 or
when the surgery required to remove the stent would be
too morbid due to location.25 Quinn et al reported a death
from sepsis (one in a series of 19 patients) within 48 hours
of stent placement using Gianturco stents (Cook Europe,
Bjaeverskov, Denmark) to treat stenosis in hemodialysis
access sites.9 He now advocates the use of prophylactic
antibiotics for all stent procedures. Latham et al supported
the use of prophylactic antibiotics for stent placement
despite no concrete evidence from published studies.40
There is little harm and cost involved in prophylaxis, as
contamination typically occurs at original operation, and
surgical repair can be morbid; therefore, our institution
recommends the use of prophylactic antibiotics prior to
implantation of an endovascular stent.4,9,12,13,15,17,19,20,24,32
Angiography suite sterility,41,42 prophylactic antibiot-
ics during subsequent procedures, and patient education
after implanting a foreign body are additional areas where
health care providers can improve upon this problem. Some
institutions have developed task forces to determine the
optimal environment for combined surgical and interven-
tional procedures.41 At our institution we utilize a fully
functional angiography suite with state-of-the-art fluoro-
scopic imaging in the rigid sterile environment of an oper-
ating room. Antibiotics should not only be administered at
the time of the initial procedure, but also during subse-
quent procedures where the risk of transient bacteremia
exists, ie, colonoscopy, dental extraction, or repeat arterial
access for subsequent procedures.11,24,29 Despite adequate
time for neointimal formation, Bunt et al reports stent
infection following cardiac catheterization that was done
22 months after initial stent placement.17 Although animal
studies suggest that at 3 months neointimal formation is
accomplished, it is hard to correlate this finding to an older
diseased human vessel.35 This would be similar to prophy-
laxis administered for patients with artificial valves. It is also
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implants in order to increase awareness of peripheral arterial
stents.7
CONCLUSION
Infection rates may be underestimated due to lack of
recognition, underreporting, and widespread application
through many different disciplinary specialties; therefore,
are likely more common than previously believed. With the
increasing number of reports as well as many cases that
likely go undiscovered or unreported, greater awareness by
health care personnel who perform endovascular interven-
tions is needed. It should not matter who performs PTA
and/or stent placement, as long as the basic principles of
periprocedural sterility are followed. Prophylactic antibiot-
ics should be administered in standard fashion. Patient
education and postoperative surveillance should be routine
with a high index of suspicion for potential stent infection
when a patient presents with any infectious complaint.
Medical cards with the type of implanted device should be
given to the patient, and patients should be instructed to
inform medical personnel of these devices prior to any
future procedure that may cause transient bacteremia.
Lastly, prompt surgical attention when a bare metal stent
infection is diagnosed is mandatory to prevent further
sequelae from the infection including sepsis, limb loss, and
death.
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